hVIVO plc (AIM:HVO)
8.30
-0.10 (-1.19%)
At close: Mar 6, 2026
hVIVO Market Cap
hVIVO has a market cap or net worth of 56.47 million as of March 6, 2026. Its market cap has decreased by -53.24% in one year.
Market Cap
56.47M
Enterprise Value
47.89M
Revenue
54.47M
Ranking
n/a
PE Ratio
10.79
Stock Price
8.30
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 56.47M, an increase of 227.60%. That is a compound annual growth rate of 19.43%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ondine Biomedical | 53.25M |
| Faron Pharmaceuticals Oy | 59.05M |
| Hemogenyx Pharmaceuticals | 62.33M |
| Bioventix | 75.76M |
| ImmuPharma | 36.70M |
| 4basebio | 83.58M |
| Poolbeg Pharma | 28.91M |
| Arecor Therapeutics | 27.18M |